Skip to main content
. 2018 Sep 20;11:241–247. doi: 10.2147/IJNRD.S176665

Table 2.

Comparison of serum anti-PLA2R antibodies among the three groups

Groups n Anti-PLA2R antibody (RU/mL)
PMN 64 226.62±366.49
SMN 40 9.09±9.75a
non-MN 60 5.11±3.80a
F 18.004
P 0

Notes: SMN and non-MN compared with PMN,

a

P<0.05. The serum anti-PLA2R antibody level in the PMN group was significantly higher than that in the SMN group and non-MN group.

Abbreviations: MN, membranous nephropathy; PMN, primary membranous nephropathy; SMN, secondary membranous nephropathy.